Image

Antiphospholipid Antibody Nephropathy Survey

Completed as of June 8, 2020

 

♦ APS ACTION International Clinical Database and Repository

Much remains to be learned about the cause, symptoms, diagnosis, and treatment for APS. The APS ACTION International Clinical Database and Repository (“Registry”) is a multi-center collaborative effort to maintain a secure, web-based clinical database of persistently aPL-positive patients so that the natural course of these patients can be followed over the next 10 years. In addition to the clinical data, blood collection is performed once a year.  Information gathered through the APS ACTION registry facilitates a better assessment of aPL-related clinical problems and helps determine the optimal management of aPL-positive patients. For general information about APS ACTION registry, please contact Joann Vega @ [email protected]. Centers participating in the APS ACTION Registry are listed below:

 

ASIA:

Peking University First Hospital, Beijing, China

Center Principal Investigator: Zhuoli Zhang

Additional Investigator: Lanlan Ji

Contact: (0086) 13810485376 — [email protected]

 

Ruijin Hospital, Shanghai, China

Center Principal Investigator: Chengde Yang

Additional Investigator: Hui Shi

Contact: [email protected]

 

Hokkaido University Hospital, Sapporo, Japan

Center Principal Investigator: Tatsuya Atsumi

Additional Investigator:  Olga Amengual

Contact: (81) 11-706-5913 — [email protected]

 

EUROPE:

Nancy University, Nancy, France

Center Principal Investigator: Denis Wahl

Additional Investigators:  Stephane Zuily

Contact: (33) 383153869 — [email protected]

 

University of Athens, Athens, Greece

Center Principal Investigator: Maria Tektonidou

Contact: (0030)- 2132061786 — [email protected]

 

University of Brescia, Brescia, Italy

Center Principal Investigator: Laura Andreoli

Additional Investigators: Angela Tincani, Cecilia Nalli

Contact: (39)- 030-3995488/7 – [email protected], [email protected]

 

University of Milan, Milan, Italy

Center Principal Investigator: Maria Gerosa

Additional Investigators: Pierluigi Meroni, Cecilia B. Chighizola

Contact: (39) 02 619112554 — [email protected]

 

University Hospital, Padova, Italy

Center Principal Investigator: Vittorio Pengo

Additional Investigators:  Elisa Bison

Contact: (39) 04 98215658 — [email protected]

 

Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

Center Principal Investigator: Giulia Pazzola

Additional Investigators: Gabriella Di Tommaso

Contact: [email protected][email protected]

 

University of Turin, Turin, Italy

Center Principal Investigator: Savino Sciascia

Additional Investigators: Silivia Foddai, Massimo Radin

Contact: (39) 0112402051 — [email protected]

 

Hospital Clinic, Barcelona, Catalonia, Spain

Center Principal Investigator: Ricard Cervera

Contact: (34) 93 2275774 — [email protected]

 

Vall d’Hebron University Hospital, Barcelona, Spain

Center Principal Investigator: Jose Pardos-Gea

Contact: [email protected]

 

Hospital Universitario Cruces, Bizkaia, Spain

Center Principal Investigator: Guillermo Ruiz-Irastorza

Additional Investigators:  Amaia Ugarte

Contact: (34) 946006348–[email protected]

 

Maimonides Institute for Biomedical Research of Cordoba, Cordoba, Spain

Center Principal Investigator: Mª Angeles Aguirre-Zamorano

Additional Investigators: Rosario López-Pedrera

Contact: [email protected][email protected]

 

Hospital Universitario 12 de Octubre, Madrid, Spain

Center Principal Investigator: Esther Rodriguez

Contact: (34) 917792238 — [email protected]

 

Istanbul University School of Medicine, Istanbul, Turkey

Center Principal Investigator: Bahar Artim-Esen

Additional Investigator:  Murat Inanc

Contact: (90) 533 425 53 36 — [email protected] 

 

NORTH AMERICA – CANADA:

CHU de Québec, pavillon CHUL, Quebec, Canada

Center Principal Investigator: Paul R. Fortin

Contact: Davy Eng–(1) 418-525-4444 ext. 48280–[email protected]

 

University of Calgary, Calgary, Alberta, Canada

Central Principal Investigator: Ann E. Clark

Additional Investigators:  Leslie Skeith, Megan Barber

Contact:  [email protected]  — [email protected][email protected]

 

NORTH AMERICA – USA: 

Johns Hopkins University, Baltimore, MD, USA

Center Principal Investigator: Michelle Petri

Contact: (1) 410-955-9114 — [email protected]

 

University of Michigan, Ann Arbor, MI, USA

Center Principal Investigator: Jason Knight

Additional Investigator: Ray Zuo

Contact: [email protected]

 

Mayo Clinic, Rochester, MN, USA

Center Principal Investigator:  Ali Duarte Garcia

Additional Investigator:  Anne E. Tebo

Contact: Shirley Ann Osei-Onomah — [email protected]

 

Northwell Health, New Hyde Park, NY, USA

Center Principal Investigator: Nina Kello

Contact: [email protected]

 

Hospital for Special Surgery, New York, NY, USA

Center Principal Investigator: Doruk Erkan

Additional Investigators: Medha Barbhaiya, Michael D Lockshin, Jane Salmon

Contact: JoAnn Vega – (1) 212 774 2795 – [email protected]

 

NYU Medical Center, New York, NY, USA

Center Principal Investigator: H. Michael Belmont

Contact: Eileen Lydon — (1) 212 598-6110 — [email protected]

 

University of Texas Medical Branch, Galveston, TX, USA

Center Principal Investigator: Rohan Willis

Additional Investigator: Emilio Gonzalez

Contact: [email protected] [email protected]

 

University of Utah, Salt Lake City, UT, USA

Center Principal Investigator: Ware D. Branch

Contact: (1) 801-581-8425 — [email protected]

 

SOUTH AMERICA:

University of Rio de Janeiro, Rio de Janeiro, Brazil

Center Principal Investigator: Guilherme de Jesus

Additional Investigators Roger Levy

Contact: (55) 21 9959-4089 — [email protected]

 

University of São Paulo, São Paulo, Brazil

Center Principal Investigator: Danieli Oliveira de Andrade

Additional Investigators: Gustavo Balbi

Contact: (55) 11-30617176 — [email protected]

 

Centro Regional de Enfermedades Autoinmunes y Reumáticas – Grupo Oroño (GO CREAR), Rosario, Santa Fe, Argentina

Center Principal Investigator: Guillermo J. Pons-Estel,

Additional Investigators: Rosana Quintana, Rosa M. Serrano

Contact: Antonela Vannucci — +54 9 (341) 6627762, +54 (341) 4261402 —[email protected] 

 

UNITED KINGDOM:

University College Hospitals London, London, UK

Center Principal Investigator: Hannah Cohen

Additional Investigators: Ian Mackie, Maria Efthymiou

Contact: [email protected]

 


♦ APS ACTION Scientific Meetings

  • 1st APS ACTION Annual Summit (APS Clinical Research Task Force International Summit), November 2-4, 2010, Miami, FL
  • 1st APS ACTION Working Meeting, May 27, 2011, London, UK
  • 2nd APS ACTION Annual Summit, November 4-5, 2011, Chicago, IL
  • 2nd APS ACTION Working Meeting, June 6, 2012, Berlin, Germany
  • 3rd APS ACTION Annual Summit, November 8-9, 2012, Washington, DC
  • 3rd APS ACTION Working Meeting, June 12, 2013, Madrid, Spain
  • 4th APS ACTION Annual Summit, September 16-17, 2013, Rio De Janeiro, Brazil
  • 4th APS ACTION Working Meeting, June 11, 2014, Paris, France
  • 5th APS ACTION Annual Summit, November 14, 2015, Boston, MA
  • 5th APS ACTION Working Meeting, June 10, 2015, Rome, Italy
  • 6th APS ACTION Annual Summit, November 6, 2015, San Francisco, CA
  • 6th APS ACTION Annual Summit (Joint Session with the 15the International Congress on Antiphospholipid Antibodies), September 22, 2016, North Cyprus
  • 7th APS ACTION Working Meeting, June 8, 2016, London, UK
  • 8th APS ACTION Annual Summit, November 3, 2017, San Diego, CA
  • 9th APS ACTION Annual Summit, October 20, 2018, Chicago, IL
  • 10th APS ACTION Annual Summit, September 17, 2019, Manchester, UK
  • 11th APS ACTION Annual Summit, November 10-11, 2020 (Virtual)
  • 12th APS ACTION Annual Summit, November 4-5, 2021 (Virtual)
  • 13th APS ACTION Annual Summit, November 17-18, 2022 (Virtual)
  • 14th APS ACTION Annual Summit, November 16-17, 2023 (Virtual)
  • 15th APS ACTION Annual Summit, November 21-22, 2024 (Virtual)
  • 16th APS ACTION Annual Summit, November 13-14, 2025 (Virtual)

 


♦ Sponsors

Special thanks to APS ACTION contributors – we appreciate support from corporations, foundations and individuals who believe in our research efforts on Antiphospholipid Syndrome.

  • APS Foundation of America
  • APS Foundation of Australia
  • APS Support UK
  • Diagnostics Reagents Limited
  • INOVA Diagnostics
  • Instrumentation Laboratory
  • New York Community Trust

With appreciation to Dr Michelle Ugolini-Lopes (Sao Paulo, Brazil) for her generous help and expertise towards our website.

If you are interested in supporting our research, please contact our Global Research Manager Joann Vega, CRCC ([email protected]; Hospital for Special Surgery, New York, NY, USA)


Social media & sharing icons powered by UltimatelySocial
LinkedIn
Share